Related Experiment Videos
Clinical and histopathological tumour progression in ECL cell carcinoids ("ECLomas")
G Qvigstad1, S Falkmer, B Westre
1Norwegian University of Science and Technology, Faculty of Medicine, Department of Medicine, University Hospital of Trondheim, Norway.
Summary
Gastric enterochromaffin-like (ECL) cell carcinoids (ECLomas) associated with hypergastrinemia can progress and metastasize. The tyramide signal amplification (TSA) technique enhances visualization of neuroendocrine features in dedifferentiated ECLomas.
Area of Science:
- Gastroenterology
- Oncology
- Pathology
Background:
- Gastric enterochromaffin-like (ECL) cell carcinoids (ECLomas) can arise secondary to hypergastrinemia.
- Understanding the malignant potential and neoplastic progression of these tumors is crucial.
Observation:
- A case of ECLoma was followed for 5 years, demonstrating classical tumor progression including lymph node, liver, and skin metastases.
- Neoplastic ECL cells showed progressive dedifferentiation with increased Ki-67 proliferation markers.
- Conventional methods showed decreased argyrophil and neuroendocrine (NE) immunoreactivity, while TSA technique significantly increased detectable NE tumor cells.
Findings:
- The tyramide signal amplification (TSA) technique effectively visualizes neuroendocrine (NE) features in dedifferentiated neoplastic ECL cells.
- Conventional immunohistochemical (IHC) methods may underestimate the extent of NE differentiation in advanced ECLomas.
Implications:
- Gastric ECLomas secondary to hypergastrinemia require close clinical and histopathological monitoring for progression.
- Early, active, and radical surgical intervention is recommended for these tumors.
- The TSA technique is a valuable tool for accurate IHC assessment of dedifferentiated NE cells in ECLomas.